A drug called retatrutide helps people lose a lot of weight—sometimes over 70 pounds—by targeting certain hormones, but it works so well that it can cause unexpected health problems.
Evidence from Studies
Supporting (2)
Community contributions welcome
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
The study shows that retatrutide causes big weight loss—up to 24% of body weight—which could mean 70+ pounds for some people. But it doesn’t show that this caused serious problems from working too well.
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
The study looks at retatrutide, the same drug in the claim, and finds it causes major weight loss and muscle loss, which supports the idea that it works very well but has side effects.
Contradicting (1)
Community contributions welcome
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
The study shows retatrutide helps people lose weight, but not as much as the claim says, and it didn’t cause serious side effects.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.